Cancer News and Research

Latest Cancer News and Research

Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

Breastfeeding associated with lower risk of developing hormone-receptor negative breast cancer

Breastfeeding associated with lower risk of developing hormone-receptor negative breast cancer

New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

Specific brain patterns can help predict success of public health campaigns

Specific brain patterns can help predict success of public health campaigns

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

Mount Sinai researchers provide a glimpse of precision medicine in action

Mount Sinai researchers provide a glimpse of precision medicine in action

Oncolytic (cancer-killing) viral therapy approved in the U.S. for use against late-stage melanoma

Oncolytic (cancer-killing) viral therapy approved in the U.S. for use against late-stage melanoma

Experts release new guidelines to improve reliability of medical tests

Experts release new guidelines to improve reliability of medical tests

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

Unproven OS benefits from surrogate endpoint-based cancer drug approvals

Unproven OS benefits from surrogate endpoint-based cancer drug approvals

IMBRUVICA (ibrutinib) wins Prix Galien USA 2015 Award in Best Pharmaceutical Agent category

IMBRUVICA (ibrutinib) wins Prix Galien USA 2015 Award in Best Pharmaceutical Agent category

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Paxman donates scalp cooling system to Huddersfield Royal Infirmary to raise awareness of breast cancer

Paxman donates scalp cooling system to Huddersfield Royal Infirmary to raise awareness of breast cancer

New studies analyse life expectancy, causes of death and child mortality in different regions of China

New studies analyse life expectancy, causes of death and child mortality in different regions of China

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Study demonstrates efficacy of everolimus in treating nonfunctional neuroendocrine tumours of the lung

Study demonstrates efficacy of everolimus in treating nonfunctional neuroendocrine tumours of the lung

FDA approves Endo’s BELBUCA (buprenorphine) buccal film for use in patients with chronic pain

FDA approves Endo’s BELBUCA (buprenorphine) buccal film for use in patients with chronic pain

New, simpler surgical intervention not better than old method for treatment of intestinal perforation

New, simpler surgical intervention not better than old method for treatment of intestinal perforation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.